Results
8521
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,521 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MX1 | AU$0.078 | -6.0% | -35.0% | AU$45.4m | AU$0.19 | PS3x | E68.7% | n/a | Healthcare | ||
SKS | AU$2.17 | 5.9% | 661.4% | AU$243.2m | AU$2.15 | PE36.7x | E24.8% | 0.5% | Capital Goods | ||
9958 | NT$160.00 | -0.3% | -26.9% | NT$41.1b | NT$238.00 | PE19.5x | E44.9% | 1.9% | Materials | ||
FND | AU$4.40 | 1.6% | 198.3% | AU$216.0m | AU$8.39 | PS3.2x | E110.7% | n/a | Diversified Financials | ||
BBT | AU$0.40 | 12.9% | 58.0% | AU$223.7m | AU$0.41 | PS3.8x | E89.2% | n/a | Consumer Services | ||
BTR | AU$0.02 | -4.8% | 66.7% | AU$142.7m | AU$0.051 | PS135.3x | E86.0% | n/a | Materials | ||
9218 | JP¥822.00 | 0.4% | -4.5% | JP¥8.5b | n/a | PE606.4x | E113.1% | n/a | Healthcare | ||
PLT | AU$0.85 | -5.6% | 21.4% | AU$149.4m | AU$1.50 | PS1.8x | E120.1% | n/a | Diversified Financials | ||
4480 | JP¥3,650.00 | -10.8% | -20.9% | JP¥118.6b | JP¥5,700.00 | PE43.7x | E27.3% | n/a | Healthcare | ||
BOE | AU$3.39 | 13.0% | -42.7% | AU$1.4b | AU$4.17 | PE31.1x | E33.9% | n/a | Energy | ||
5038 | JP¥1,830.00 | -5.7% | -3.7% | JP¥27.7b | JP¥2,290.00 | PE38.6x | E28.8% | 0.6% | Healthcare | ||
7096 | JP¥1,527.00 | 1.7% | -28.8% | JP¥15.6b | n/a | PE37.1x | E42.1% | 1.6% | Healthcare | ||
7373 | JP¥1,855.00 | 5.6% | -9.7% | JP¥28.4b | JP¥4,700.00 | PE19x | E23.1% | 1.6% | Commercial Services | ||
7685 | JP¥2,768.00 | -1.3% | 85.5% | JP¥79.3b | JP¥3,537.50 | PE31.6x | E27.4% | 0.5% | Retail | ||
CUV | AU$11.56 | -4.2% | -28.0% | AU$577.4m | AU$28.23 | PE16.2x | E26.2% | 0.4% | Pharmaceuticals & Biotech | ||
INIT | SEK 7.15 | 1.4% | -12.4% | SEK 409.8m | SEK 22.50 | PB16.8x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
RMDA | ج.م3.67 | -1.1% | 66.8% | ج.م5.6b | ج.م5.02 | PE20.7x | E30.7% | 1.8% | Pharmaceuticals & Biotech | ||
CADLR | NOK 60.20 | 2.4% | 25.1% | NOK 21.0b | NOK 81.81 | PE198.4x | E70.7% | n/a | Capital Goods | ||
PHM | €91.90 | 6.8% | 150.5% | €1.6b | €86.40 | PE2571.8x | E44.7% | 0.7% | Pharmaceuticals & Biotech | ||
ICOP | €7.80 | -2.3% | n/a | €216.1m | €9.80 | PE42.7x | E49.2% | n/a | Capital Goods | ||
AGP | €5.30 | -5.7% | -26.6% | €93.3m | €12.85 | PE13.6x | E22.1% | n/a | Capital Goods | ||
MVW | NOK 9.70 | -4.9% | 10.0% | NOK 319.0m | NOK 11.70 | PS16.6x | E71.7% | n/a | Materials | ||
AFISH | NOK 64.00 | -3.8% | 10.3% | NOK 2.1b | NOK 81.00 | PE62.6x | E65.4% | n/a | Food, Beverage & Tobacco | ||
ACE | SEK 2.83 | 1.6% | -64.1% | SEK 272.5m | SEK 8.25 | PB2.5x | E47.2% | n/a | Pharmaceuticals & Biotech |